Le Lézard
Classified in: Health
Subjects: PDT, SVY

Safety and Efficacy of Lidocaine and Collagen in Wound Care


RegeneCare HAtm and TripleHelixtm data from the Symposium on Advanced Wound Care

MESQUITE, Texas, May 30, 2024 /PRNewswire/ -- MPM Medical, a developer and distributor of advanced wound care products, has presented new data on two flagship products?TripleHelixtm Collagen, a 100% Type I Bovine Collagen, and RegeneCare HAtm, a 2% Lidocaine Hydrogel with an aloe vera base containing collagen and hyaluronic acid.

Studies have highlighted the TripleHelixtm collagen powder's ability to reduce erythema and edema, as well as provide a greater reduction in wound size when compared to the standard wound dressing. RegeneCare HAtm was noted as not significantly increasing the risk for lidocaine toxicity. The study also suggests that RegeneCare HAtm is a preferable alternative to topical lidocaine to control pain and promote wound healing.

The data and new branding were showcased at the 2024 Symposium on Advanced Wound Care (SAWC) Spring Conference in Orlando, Florida. Posters are now available online:

Caitlin Crews-Stowe, Ph.D., MPH, CPH, CIC, CPHQ, VA-BC, presented the data and noted, "Chronic wounds have been called our 'silent epidemic'. Finding a safe and effective alternative to traditional dressings to treat these wounds, as well as stagnant and hard-to-heal wounds, is crucial. We are thrilled to share the results on TripleHelix."

Nathan Lavalle, CWCMS, MPM Medical National Sales Manager adds, "The wound care professionals that we serve care tremendously about their patients. They are in dire need of safe and effective solutions for patients with painful wounds. We are proud to offer them a proven and unique product with RegeneCare HA".

To learn more about these studies and the unique, advanced wound care products offered by MPM Medical, join Dr. Stowe and Nathan this summer for a complimentary webinar over safety and efficacy data:

In addition to showcasing new data, MPM Medical was featured as a new product spotlight and unveiled its new corporate branding and product packaging. The new packaging, as well as new ExcelSAPtm silicone super absorbent dressing sizes, will be available later this year. View the entire advanced wound care product line on MPM Medical's new website, mpmmed.com.

About MPM Medical
Since 1992, MPM Medical has been dedicated to the development and distribution of Medical Products that Mattertm. With a focus on innovation in the advanced wound care industry, MPM Medical collaborates with clinicians and surgeons to pioneer new and enhanced products that significantly impact patient outcomes such as the 100% Type I Bovine Collagen line, ACM Surgicaltm, MetaMatrixtm, and TripleHelixtm Wound Care Collagen. All sales specialists are certified wound care experts and samples are always complimentary, including well-known brands like RegeneCare HAtm, ExcelSAPtm, SilverMedtm, CoolMagictm, and DryMaxtm. MPM Medical is committed to advancing healthcare through excellence in product development, quality, and service. Visit mpmmed.com to learn more.

About TripleHelixtm Wound Care Collagen
TripleHelixtm Wound Care Collagen is a 100% Type I Bovine Collagen available in powders, pads, and rope formats. TripleHelixtm is indicated for Partial- and Full-Thickness Wounds, Pressure (Stage I-IV) and Venous Ulcers, Ulcers Caused by Mixed Vascular Etiologies, Venous Stasis and Diabetic Ulcers, First- and Second-Degree Burns, as well as Cuts, Abrasions, and Surgical Wounds. Visit the product page to learn more.

About RegeneCare HAtm 2% Lidocaine Hydrogel
RegeneCare HAtm is a unique aloe vera-based hydrogel containing 2% lidocaine, collagen, and hyaluronic acid. RegeneCare HAtm reduces pain and inflammation while helping to break the itch-and-scratch cycle. It is available in gel and spray formats. Visit the product page to learn more.

CONTACT:
Marissa Ransdell, MBA
[email protected] 

SOURCE MPM Medical


These press releases may also interest you

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

3 jui 2024
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

3 jui 2024
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...



News published on and distributed by: